Taiwan's Acer Medical launches AI diagnostic tools across Thai hospitals
Acer Medical, a Taiwan-based startup, has partnered with New Eye Inc. and Upsynergy Taiwan to deploy AI-powered ophthalmology solutions in Thailand. The collaboration secured approval from Thailand's Food and Drug Administration and won a government telemedicine project spanning five hospitals in Phuket Province.
The partnership integrates three components: ophthalmic devices, AI diagnostic software called VeriSee, and telemedicine services. Phuket Provincial Hospital is now using Acer Medical's ARC-1000 non-mydriatic fundus camera paired with VeriSee DR to screen and monitor diabetic patients.
Why this matters for healthcare professionals
Healthcare systems globally face pressure from aging populations and uneven resource distribution. Thailand's adoption of these tools addresses a practical need: expanding diagnostic capacity without proportional increases in specialist availability.
The telemedicine component extends screening to underserved areas. Remote diagnostics allow specialists to review results from peripheral hospitals, reducing patient travel and wait times.
What's being deployed
- VeriSee DR: AI-assisted diagnostic system for diabetic retinopathy screening
- ARC-1000: Non-mydriatic fundus camera for retinal imaging without pupil dilation
- Telemedicine infrastructure connecting five regional hospitals
The ARC-1000 camera captures retinal images without dilating drops, reducing appointment time and improving patient experience-a practical advantage in high-volume screening settings.
Learn more about AI for Healthcare applications and implementation strategies.
Your membership also unlocks:
